Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance
Sha Zhang et al, 2020, OncoTargets and Therapy CrossRef
Elevated PRC1 in gastric carcinoma exerts oncogenic function and is targeted by piperlongumine in a p53‐dependent manner Bin Zhang et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
Silencing RRM2 inhibits multiple myeloma by�targeting the Wnt/β‑catenin signaling pathway Xia Liu et al, 2019, Molecular Medicine Reports CrossRef
Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2 Yoichi Osako et al, 2019, International Journal of Oncology CrossRef
Identification of Novel Genes and Associated Drugs in Advanced Clear Cell Renal Cell Carcinoma by Bioinformatic Methods Meiqi Lu et al, 2022, The Tohoku Journal of Experimental Medicine CrossRef
Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value Yangmei Zhou et al, 2019, BioMed Research International CrossRef
siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin Shuquan Zheng et al, 2018, Molecular Therapy - Nucleic Acids CrossRef
Downregulation of ribonucleotide reductase subunits M2 induces apoptosis and G1 arrest of cervical cancer cells Nan Wang et al, 2018, Oncology Letters CrossRef